These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 28371247

  • 1. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 2. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 3. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Dec 01; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 4. New medications for heart failure.
    Gordin JS, Fonarow GC.
    Trends Cardiovasc Med; 2016 Aug 01; 26(6):485-92. PubMed ID: 27038558
    [Abstract] [Full Text] [Related]

  • 5. Ivabradine in heart failure: hope or hype?
    Deedwania PC.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):357-9. PubMed ID: 23181943
    [No Abstract] [Full Text] [Related]

  • 6. Update on ivabradine for heart failure.
    Borer JS, Tavazzi L.
    Trends Cardiovasc Med; 2016 Jul 01; 26(5):444-9. PubMed ID: 26934996
    [Abstract] [Full Text] [Related]

  • 7. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
    Foster JL, Bobadilla RV.
    J Am Assoc Nurse Pract; 2016 Nov 01; 28(11):576-582. PubMed ID: 27215699
    [Abstract] [Full Text] [Related]

  • 8. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 9. Role of ivabradine and heart rate lowering in chronic heart failure: guideline update.
    Chow SL, Page RL, Depre C.
    Expert Rev Cardiovasc Ther; 2018 Jul 27; 16(7):515-526. PubMed ID: 29902387
    [Abstract] [Full Text] [Related]

  • 10. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
    Cardiol J; 2015 Jul 27; 22(2):227-32. PubMed ID: 25179314
    [Abstract] [Full Text] [Related]

  • 11. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC, Reil GH, Böhm M.
    Trends Cardiovasc Med; 2009 Jul 27; 19(5):152-7. PubMed ID: 20005474
    [Abstract] [Full Text] [Related]

  • 12. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D, Borer JS.
    Drugs; 2007 Jul 27; 67 Suppl 2():15-24. PubMed ID: 17999560
    [Abstract] [Full Text] [Related]

  • 13. Ivabradine for treatment of heart failure.
    Bocchi EA, Salemi VMC.
    Expert Opin Drug Saf; 2019 May 27; 18(5):393-402. PubMed ID: 31074301
    [Abstract] [Full Text] [Related]

  • 14. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
    Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, SHIFT Investigators.
    J Am Coll Cardiol; 2012 May 29; 59(22):1938-45. PubMed ID: 22617188
    [Abstract] [Full Text] [Related]

  • 15. Time to benefit of heart rate reduction with ivabradine in patients with heart failure and reduced ejection fraction.
    Böhm M, Abdin A, Slawik J, Mahfoud F, Borer J, Ford I, Swedberg K, Tavazzi L, Batailler C, Komajda M.
    Eur J Heart Fail; 2023 Aug 29; 25(8):1429-1435. PubMed ID: 37092340
    [Abstract] [Full Text] [Related]

  • 16. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A, Makharadze T, Gvishiani M.
    Georgian Med News; 2015 Apr 29; (241):44-9. PubMed ID: 25953938
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure.
    Das D, Savarese G, Dahlström U, Fu M, Howlett J, Ezekowitz JA, Lund LH.
    Circ Heart Fail; 2017 Sep 29; 10(9):. PubMed ID: 28903983
    [Abstract] [Full Text] [Related]

  • 18. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L, Fragasso G, Spoladore R, Pinto G, Gemma M, Slavich M, Godino C, Salerno A, Montanaro C, Margonato A.
    J Cardiovasc Med (Hagerstown); 2018 Jul 29; 19(7):351-356. PubMed ID: 29762337
    [Abstract] [Full Text] [Related]

  • 19. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL, Francis KE, Lowe DK, Cahoon WD.
    Ther Adv Cardiovasc Dis; 2016 Dec 29; 10(6):348-352. PubMed ID: 27659287
    [Abstract] [Full Text] [Related]

  • 20. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
    Guzman M, Gomez R, Romero SP, Aranda R, Andrey JL, Pedrosa MJ, Egido J, Gomez F.
    Int J Clin Pract; 2018 Nov 29; 72(11):e13217. PubMed ID: 30248211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.